
Source: iQoncept / Shutterstock
CureVac (NASDAQ:CVAC) just reported results for the fourth quarter of 2023.
- CureVac reported earnings per share of -41 cents. This was below the analyst estimate for EPS of -20 cents.
- The company reported revenue of $24.53 million.
- This was 31.77% worse than the analyst estimate for revenue of $35.96 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/cvac-stock-earnings-curevac-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC